These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 27490240)

  • 1. KIR and HLA Genotypes Implicated in Reduced Killer Lymphocytes Immunity Are Associated with Vogt-Koyanagi-Harada Disease.
    Levinson RD; Yung M; Meguro A; Ashouri E; Yu F; Mizuki N; Ohno S; Rajalingam R
    PLoS One; 2016; 11(8):e0160392. PubMed ID: 27490240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A study of KIR genes and HLA-C in Vogt-Koyanagi-Harada disease in Saudi Arabia.
    Sheereen A; Gaafar A; Iqneibi A; Eldali A; Tabbara KF; Adra C; Al-Hussein K
    Mol Vis; 2011; 17():3523-8. PubMed ID: 22219647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Killer cell immunoglobulin-like receptor gene-cluster 3DS1-2DL5-2DS1-2DS5 predisposes susceptibility to Vogt-Koyanagi-Harada syndrome in Japanese individuals.
    Levinson RD; Okada AA; Ashouri E; Keino H; Rajalingam R
    Hum Immunol; 2010 Feb; 71(2):192-4. PubMed ID: 19897003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KIR and HLA gene combinations in Vogt-Koyanagi-Harada disease.
    Levinson RD; Du Z; Luo L; Holland GN; Rao NA; Reed EF; Rajalingam R
    Hum Immunol; 2008 Jun; 69(6):349-53. PubMed ID: 18571006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compound KIR-HLA genotype analyses in the Iranian population by a novel PCR-SSP assay.
    Tajik N; Shahsavar F; Nasiri M; Radjabzadeh MF
    Int J Immunogenet; 2010 Jun; 37(3):159-68. PubMed ID: 20193031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA and killer cell immunoglobulin-like receptor (KIRs) genotyping in patients with acute ischemic stroke.
    Tuttolomondo A; Di Raimondo D; Pecoraro R; Casuccio A; Di Bona D; Aiello A; Accardi G; Arnao V; Clemente G; Corte VD; Maida C; Simonetta I; Caruso C; Squatrito R; Pinto A;
    J Neuroinflammation; 2019 Apr; 16(1):88. PubMed ID: 30995924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A shared HLA-DRB1 epitope in the DR beta first domain is associated with Vogt-Koyanagi-Harada syndrome in Indian patients.
    Tiercy JM; Rathinam SR; Gex-Fabry M; Baglivo E
    Mol Vis; 2010 Mar; 16():353-8. PubMed ID: 20216938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA class I NK-epitopes and KIR diversities in patients with multiple myeloma.
    Beelen NA; Molenbroeck SJJ; Groeneveld L; Voorter CE; Bos GMJ; Wieten L
    Immunogenetics; 2024 Jun; 76(3):155-164. PubMed ID: 38478091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of HLA-DR4/HLA-DRB1*04 with Vogt-Koyanagi-Harada disease: a systematic review and meta-analysis.
    Shi T; Lv W; Zhang L; Chen J; Chen H
    Sci Rep; 2014 Nov; 4():6887. PubMed ID: 25382027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of killer cell immunoglobulin-like receptor (KIR) genes and human leukocyte antigen (HLA) class I ligands on predisposition or protection against prostate cancer.
    Roshan Zamir M; Ariafar A; Ghaderi A; Amirzargar A
    Immunobiology; 2023 Mar; 228(2):152319. PubMed ID: 36599262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imbalance of Genes Encoding Natural Killer Immunoglobulin-Like Receptors and Human Leukocyte Antigen in Patients With Biliary Cancer.
    Cornillet M; Jansson H; Schaffer M; Hertwig L; Berglin L; Zimmer CL; Johansson H; Ellis E; Isaksson B; Gonzalez-Galarza FF; Middleton D; Malmberg KJ; Sparrelid E; Björkström NK
    Gastroenterology; 2019 Oct; 157(4):1067-1080.e9. PubMed ID: 31229495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural killer-cell immunoglobulin-like receptors trigger differences in immune response to SARS-CoV-2 infection.
    Littera R; Chessa L; Deidda S; Angioni G; Campagna M; Lai S; Melis M; Cipri S; Firinu D; Santus S; Lai A; Porcella R; Rassu S; Meloni F; Schirru D; Cordeddu W; Kowalik MA; Ragatzu P; Vacca M; Cannas F; Alba F; Carta MG; Del Giacco S; Restivo A; Deidda S; Palimodde A; Congera P; Perra R; Orrù G; Pes F; Loi M; Murru C; Urru E; Onali S; Coghe F; Giglio S; Perra A
    PLoS One; 2021; 16(8):e0255608. PubMed ID: 34352002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Killer cell immunoglobulin-like receptors influence the innate and adaptive immune responses.
    Rajalingam R
    Iran J Immunol; 2007 Jun; 4(2):61-78. PubMed ID: 17652846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of killer cell immunoglobulin-like receptors (KIRs) and their HLA ligand genes polymorphisms in Iranian patients with systemic sclerosis.
    Mahmoudi M; Fallahian F; Sobhani S; Ghoroghi S; Jamshidi A; Poursani S; Dolati M; Hosseinpour Z; Gharibdoost F
    Clin Rheumatol; 2017 Apr; 36(4):853-862. PubMed ID: 28120169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variants in IL23R-C1orf141 and ADO-ZNF365-EGR2 are associated with susceptibility to Vogt-Koyanagi-Harada disease in Japanese population.
    Sakono T; Meguro A; Takeuchi M; Yamane T; Teshigawara T; Kitaichi N; Horie Y; Namba K; Ohno S; Nakao K; Sakamoto T; Sakai T; Nakano T; Keino H; Okada AA; Takeda A; Ito T; Mashimo H; Ohguro N; Oono S; Enaida H; Okinami S; Horita N; Ota M; Mizuki N
    PLoS One; 2020; 15(5):e0233464. PubMed ID: 32437414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Receptor systems controlling natural killer cell function are genetically stratified in Europe.
    Guinan KJ; Cunningham RT; Meenagh A; Dring MM; Middleton D; Gardiner CM
    Genes Immun; 2010 Jan; 11(1):67-78. PubMed ID: 19693090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between Vogt-Koyanagi-Harada syndrome and HLA-DR1 and -DR4 in Hispanic patients living in southern California.
    Weisz JM; Holland GN; Roer LN; Park MS; Yuge AJ; Moorthy RS; Forster DJ; Rao NA; Terasaki PI
    Ophthalmology; 1995 Jul; 102(7):1012-5. PubMed ID: 9121744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring the Role of Killer Cell Immunoglobulin-Like Receptors and Their HLA Class I Ligands in Autoimmune Hepatitis.
    Littera R; Chessa L; Onali S; Figorilli F; Lai S; Secci L; La Nasa G; Caocci G; Arras M; Melis M; Cappellini S; Balestrieri C; Serra G; Conti M; Zolfino T; Casale M; Casu S; Pasetto MC; Barca L; Salustro C; Matta L; Scioscia R; Zamboni F; Faa G; Orrù S; Carcassi C
    PLoS One; 2016; 11(1):e0146086. PubMed ID: 26744892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of "Killer Immunoglobulin-Like Receptor /Ligand" Genotypes on Outcome following Surgery among Patients with Colorectal Cancer: Activating KIRs Are Associated with Long-Term Disease Free Survival.
    Beksac K; Beksac M; Dalva K; Karaagaoglu E; Tirnaksiz MB
    PLoS One; 2015; 10(7):e0132526. PubMed ID: 26181663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding the killer-cell immunoglobulin like receptor polymorphism in retinoblastoma.
    Aggarwal R; Sharma M; Singh U; Poulton K; Bhatia T; Mangat N; Kakkar N; Bansal D
    Ophthalmic Genet; 2023 Feb; 44(1):1-5. PubMed ID: 36594723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.